In contrast, pharmacodynamic PNR occurs when active disease persists despite therapeutic biologic drug levels, which implies that the binding of the drug to TNF is blocked or the presence of a non-inflammatory complication such as stenosis, abscess or a superimposed infection that has not been recognized; or that the underlying disease pathophysiology is primarily driven by inflammatory mediators other than TNF. The gene discussed is TNF; the disease is abscess.